You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Bioactive Polymer Designed for Cardiac Assist Devices

    SBC: ABIOMED, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The ultimate objective of this proposal is the development of a novel, bioactive polymer for use in ventricular assist devices (VAD), and other long-term blood contacting implantable devices. Although VADs are becoming an important therapeutic option for patients in heart failure, serious problems persist secondary to thromboembolic complications and continue t ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  2. An Artificial Myocardium for Pediatric Support

    SBC: ABIOMED, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The ultimate objective of this proposal is the commercialization of a pediatric ventricular assist device (VAD). Although, VADs, both implantable and paracorporeal, have become an important surgical option for adult patients with myocardial failure unresponsive to less aggressive therapy, no VADs are commercially available for short-term use in children or smal ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  3. Flight Test Development of the X43A-LS Reusable Launch Vehicle

    SBC: ACCURATE AUTOMATION CORPORATION            Topic: N/A

    Accurate Automation Corporation proposes a three-pronged effort to build on the Phase I program to develop technologies in support of the NASA Hyper-X program and the X-43 series of research vehicles (X-43A, X-43B, and X-43C). The data and technologies developed under the proposed Phase II program will also support the development and testing of future hypersonic vehicles and reusable launch vehic ...

    SBIR Phase II 2003 National Aeronautics and Space Administration
  4. Plasma Limiter: RF Mitigation Device for Radar and Electronic Warfare Systems

    SBC: ACCURATE AUTOMATION CORPORATION            Topic: N/A

    The widespread use of communication devices and radar systems has made our society increasingly vulnerable to disruptive, high-power, short pulse electromagnetic interference (EMI) and high power microwaves (HPM). Significant advances in devices thatproduce these high-power, short pulses have been made in the US and abroad in the past few decades. As a result, the need for devices that can prote ...

    SBIR Phase I 2003 Department of DefenseNavy
  5. Plasma Limiter: RF Mitigation Device for Operation in Stressing Environments

    SBC: ACCURATE AUTOMATION CORPORATION            Topic: N/A

    The widespread use of communication devices and radar systems has made our society increasingly vulnerable to disruptive, high-power, short pulse electromagnetic interference (EMI) and high power microwaves (HPM). Significant advances in devices thatproduce these high-power, short pulses have been made in the US and abroad in the past few decades. As a result, the need for devices that can prote ...

    SBIR Phase I 2003 Department of DefenseMissile Defense Agency
  6. SBIR Phase II: Advanced Phased Array Ultrasound Instrument for Nondestructive Evaluation (NDE)

    SBC: ACOUSTIC IDEAS, INC.            Topic: N/A

    This SBIR Phase II research project strives to develop an Advanced Ultrasonic Beamformer that is unparalleled in its scalability and signal processing features. The ultrasonic beamformer architecture will be unique in its breadth of features. The architecture was developed as the superset of features across several fields including medical imaging, medical therapy, bone density measurement, vascul ...

    SBIR Phase I 2003 National Science Foundation
  7. New Agents That Inhibit Fatty Acid Accumulation

    SBC: ADIPOGENIX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. Although weight loss is the most effective treatment for type 2 diabetes, current methods for reducing weight typically are insufficient for long-term weight loss. The mission of AdipoGenix, Inc. is to discover, develop and license novel the ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  8. Activators of Adipocyte Fatty Acid Oxidation

    SBC: ADIPOGENIX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. Existing drug and dietary treatments for obesity are only modestly effective. An approach that is very likely to be effective in treating obesity and with a good side effect profile is a drug that acts directly on lipid metabolism in the fat ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  9. Computer-Aided Design Tools for Three-Dimensional Circuit Integration

    SBC: R3LOGIC, INC.            Topic: N/A

    R3 Logic proposes to develop an openly accessible Design Environment that will incorporate CAD tools needed for the analysis and design of 3D integrated circuits, including schematic capture, VHDL interfaces, 3D physical layout, verification, 3D parasiticextraction, interactive coupled electro-thermal simulations, and thermally-aware place and route methods. We will achieve this goal, first by bui ...

    SBIR Phase II 2003 Department of DefenseDefense Advanced Research Projects Agency
  10. Improved Outcome Prediction In Galactosemic Newborns

    SBC: ADVANCED BREATH DIAGNOSTICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Galactosemia is a potentially lethal, but preventable, disease of newborns. In Phase I of this grant, we demonstrated that a 13C-galactose breath test could be used to assess the degree of impairment of whole body galactose oxidation in more than 90 galactosemic children with a broad spectrum of mutations in the human GALT gene that codes for galactose-l-phosph ...

    SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government